Home
About
Overview
Sharing Data
ORCID
Help
History (1)
JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells.
JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells. Oncogene. 2019 07; 38(28):5643-5657.
View in:
PubMed
subject areas
Antineoplastic Agents
Ataxia Telangiectasia Mutated Proteins
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Checkpoint Kinase 1
Cisplatin
Drug Resistance, Neoplasm
Histones
Humans
Jumonji Domain-Containing Histone Demethylases
Lung Neoplasms
Methylation
authors with profiles
Carl Maki
Lei Duan